 HAYWARD, Calif., Sept. 13, 2021 PRNewswire -- Benitec Biopharma, Inc. NASDAQ: BNTC, a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ddRNAi platform, today announced that Jerel A. 